Licenses to UK Startup Companies

FY 2012  | FY 2011  | FY 2010  | FY 2009  | FY 2008  | FY 2007  | FY 2006  | FY 2005

UK currently has a total of 172 licenses with our startup companies and business & industry.

FY 2012 Licenses to UK startups

The following are to-date new licenses for Fiscal Year 2012, July 1, 2011 to June 30, 2012.

• Minova USA has licensed a technology for the production and use of rapidly hardening ettringite-based cement systems. The inventor is Tom Robl, Center for Applied Energy Research.
• Pioneer Hi-Bred International has licensed a technology for full-length transcript promoters from figwort mosaic caulimovirus. The technology is from Indu Maiti, plant and soil sciences and Kentucky Tobacco Research and Development Center, and Robert J. Shepherd, retired, plant and soil sciences.
• Kentucky Specialty Grains has licensed a technology for an early flowering chia. The inventors are David Hildebrand and Tim Phillips, plant and soil sciences.
• Direct i2i Technologies is developing a technology for long range iris sensing. The technology is from Ruigang Yang, computer science and the Center for Visualization and Virtual Environments.
• Mosquito Mate, founded by UK entomologist Steve Dobson, is using Dobson's technology to limit mosquito-borne pathogens and control or prevent mosquito-borne disease such as Dengue fever.
• PhylloTech is pioneering the use of protein-based biofungicides to fight pathogens in the agricultural industry by developing new techniques for the sustainable production of industrial biomaterials in plants. The technology is from George Wagner, UK plant & soil sciences and PhylloTech CSO, and Ryan Shepherd, CTO and UK Ph.D. in plant biochemistry & molecular biology.

FY 2011 Licenses to UK startups

FY 2012  | FY 2011  | FY 2010  | FY 2009  | FY 2008  | FY 2007  | FY 2006  | FY 2005

• Summit Biosciences is developing a synthetic THC nasal spray product with funding from the qualifying therapeutic discovery project program. The nasal spray was developed by UK researcher Dan Wermeling in the College of Pharmacy to treat nausea and vomiting associated with cancer chemotherapy. Located at the UK Coldstream Research Campus.
• Direct i2i Technologies uses high definition video and audio collaboration to create the next generation of teleconferencing systems. Ruigang Yang, computer science and the Center for Visualization & Virtual Environments, is developing hardware and software to digitally synthesize images for eye to eye contact in video teleconferences.
• TrackFive Diagnostics is developing genomic-based personalized medical tests to predict patient response to targeted cancer treatments to improve cancer care and reduce health care costs. The license is based on research by Penni Black, pharmaceutical sciences.
• Seikowave is developing three dimensional imaging technologies for medical, security and industrial imaging applications that will enable high performance, low cost 3D imaging solutions capable of capturing human motion in real time. The license is based on research by Daniel Lau of the Center for Visualization & Virtual Environments and computer and electrical engineering. Seikowave has an office in Japan and a lab in the ASTeCC campus incubator.
• Medical Scan Technologies is developing medical diagnostic products based on lock and hold structured light illumination. The license is based on research by Larry Hassebrook and Daniel Lau, electrical and computer engineering and the Center for Visualization & Virtual Environments. Located in Dallas, Texas.
• XtremeCarbons is developing aligned carbon nanotube materials for thermal, electrical and mechanical applications. The license is based research by Rodney Andrews, David Jacques and Brock Marrs, Center for Applied Energy Research.

FY 2010 Licenses to UK startups

FY 2012  | FY 2011  | FY 2010  | FY 2009  | FY 2008  | FY 2007  | FY 2006  | FY 2005

• Amchael Graphics is developing a square tube, mirror-based imaging system. Based on research by Fuhua "Frank" Cheng, computer science. Located in Lexington, Ky.
• Equine Diagnostic Solutions (3 licenses) is developing diagnostic tests for sarcocystis neurona in horses. Licenses based on research by Daniel K. Howe of the Department of Veterinary Science. Located at the UK Coldstream Research Campus.
• Escent Technologies is developing a portable device using near-infrared spectroscopy. Based on research by Robert Lodder, pharmaceutical sciences, electrical & computer engineering and chemistry. Located in the ASTeCC campus incubator.
• CoPlex Therapeutics, co-founded by UK Department of Chemistry researchers Burt Lynn and Mark Lovell and CEO John Beran, is developing treatments for mild cognitive impairment, Alzheimer's and other neurological disorders. Located in the ASTeCC campus incubator.
• i-Glyco (2 licenses) is developing glucose monitoring technology. Licenses based on research by Sylvia Daunert, Elisabeth Moschou, Joel Smita, chemistry, and Ping Wang, Jonathan Siegrist, Marc Madou, University of California, Irving. Located in California.
• Secure Analytics is developing a data shuffling procedure for masking data. Based on research by Krish Muralidhar, Gatton College of Business & Economics, and Rathindra Sarathy, Oklahoma State University. Located in Stillwater, Okla.
• Therix Medical is developing a catheter invented by John Gurley, interventional cardiology, UK Gill Heart Institute, and an infant garment for the prevention of positional plagiocephaly from concepts by Claire Sanger, formerly plastic surgery. Kentucky Technology Inc., UK's for-profit corporation, is the founder of Therix.

FY 2009 Licenses to UK startups

FY 2012  | FY 2011  | FY 2010  | FY 2009  | FY 2008  | FY 2007  | FY 2006  | FY 2005

• Alkymos is designing, synthesizing and manufacturing chelators and chelator-based devices for laboratory, industrial, animal, and human applications. The license is based on research by Robert Yokel and Chang-Guo Zhan, pharmacy. Located in Lexington, Ky.
• HiberNetics is developing treatments for ischemia and reperfusion injury. Licenses based on research by Peter Oeltgen, pathology. Located in Frankfort, Ky.
• IP Pharmaceuticals (2 licenses) is developing stable cell lines that produce hepatitis C virus. Based on research by Guangxiang Luo, biochemistry. Located in the ASTeCC incubator at the University of Kentucky.
• Merloc is developing a multidentate sulfur-containing ligands for binding heavy metals for waste management or environmental cleanup applications. Based on research by David Atwood, chemistry. Located in Lexington, Ky.
• NanoMed Pharmaceuticals is developing a bio-adhesive berry gel for oral cancer treatment. Based on research by Russ Mumper, formerly in pharmacy. Located in Kalamazoo, Mich.
• NuForm Materials is developing methods for the processing of coal combustion ash and isolation of specific fractions useful as polymer fillers, metal matrix and high performance pozzolans. Based on research by Tom Robl, Center for Applied Energy Research. Located in Sadieville, Ky.
• Scout Diagnostics is developing a new diagnostic tool using biomarkers to detect Alzheimer's disease prior to clinical diagnosis. Based on research by Mark Lovell and Burt Lynn, chemistry. Located in the ASTeCC incubator at the University of Kentucky.
• TranSecurity Systems is developing a wireless milk transport security system. Based on research by Fred Payne, biosystems and agricultural engineering. Located in Lexington, Ky
• ViroTac is developing antibodies and viral enzymes. Based on research by Guangxiang Luo, biochemistry. Located in Lexington, Ky.

FY 2008 Licenses to UK startups

FY 2012  | FY 2011  | FY 2010  | FY 2009  | FY 2008  | FY 2007  | FY 2006  | FY 2005

• Alkymos is developing, designing, synthesizing, evaluating, and manufacturing chelators and chelator-based devices for laboratory, industrial, animal, and human applications. Based on research by Bob Yokel, pharmacy. Located in Lexington, Kentucky
• Cherry Orchard Products is developing a dental wax containing benzocaine for use in orthodontic patients. Based on research by Mike Jay, formerly pharmacy and Thomas Kluemper, dentistry. Located in Chapel Hill, North Carolina
• Fresh Flavors and Fragrances is developing a production system for green note compounds and other flavor and flavor and fragrance compounds. Based on research by David Hildebrand, agriculture. Located in Owensboro, Kentucky
• IP Pharmaceuticals (2 licenses) is developing stable cell lines that produce HCV (hepatitis C virus). Based on research by Guangxiang Luo, medicine. Located in ASTeCC, UK's campus incubator
• MCC Technologies (1 license/1 option) is developing methods for improving fly ash for use in concrete. Based on research by Tom Robl and Jack Groppo, Center for Applied Energy Research. Located in New York, New York
• Michael Troy is developing lock and hold structured light illumination. Based on research by Larry Hassebrook, engineering. Located in Dallas, Texas
• TranSecurity Systems is developing a wireless electronic system for securing milk from farm to processor. Based on research by Fred Payne, agriculture. Located in Lexington, Kentucky
• ViroTac is developing antibodies and viral enzymes. Based on research by Guangxiang Luo, biochemistry. Located in Lexington, Kentucky

FY 2007 Licenses to UK startups

FY 2012  | FY 2011  | FY 2010  | FY 2009  | FY 2008  | FY 2007  | FY 2006  | FY 2005

• Mersive Technologies (4 licenses) is developing and redefining the ease with which high-resolution, multi-projector displays can be designed, configured, and maintained. Using the Mersive SolTM Server customers can create unprecedented displays in non-traditional configurations and resolutions. Based on research by Christopher Jaynes, engineering. Located in Lexington, KY. www.mersive.com
• Nano-Mite Technologies has developed and is currently testing a nano-scale medical device that serves as mitochondrial uncouplers to increase metabolism and result in weight loss. Nano-Mite is focused on controlling obesity — in both humans and pets — using nanotechnology. Based on research by Pat Sullivan, medicine. Located in ASTeCC.
• Agama is developing a data shuffling procedure for masking data. Based on research by Krish Muralidhar, business & economics. Located in Lexington, KY.
• Alkymos is developing, designing, synthesizing, evaluating, and manufacturing chelators and chelator-based devices for laboratory, industrial, animal, and human applications. Based on research by Bob Yokel, pharmacy. Located in Lexington, KY.
• Scout Diagnostics is developing and marketing a new early diagnostic test for Alzheimer's disease. The testing kit will detect Alzheimer's at an early stage with greater sensitivity and specificity than is available using current techniques. Based on research by Mark Lovell and Burt Lynn, chemistry. Located in ASTeCC. www.scoutdiagnostics.com
• Haley Tech is working to develop water soluble chelators. Based on research by Boyd Haley, chemistry. Located in Lexington, KY.
• IP Pharmaceuticals is developing stable cell lines that produce HCV (hepatitis C virus). Based on research by Guangxiang Luo, medicine. Located in ASTeCC.
• Four Tigers is developing a pipeline of blackberry-based health products that will be marketed as cosmetics, dietary supplements and foods. The company also is developing medical products harnessing the potent anti-inflammatory and anti-oxidant properties of blackberries. Based on research by Russ Mumper. Corporate office located in Paris, KY. www.four-tigers.com

FY 2006 Licenses to UK startups

FY 2012  | FY 2011  | FY 2010  | FY 2009  | FY 2008  | FY 2007  | FY 2006  | FY 2005

• AllTranz is developing transdermal delivery of opioid antagonist prodrugs for use in treating addiction and novel oral bioavailable prodrugs, also for use in treating addiction. Based on research by Audra Stinchcomb, pharmacy. Corporate office in Lexington, KY.
• Four Tigers is developing a pipeline of blackberry-based health products that will be marketed as cosmetics, dietary supplements, and foods. The company is also developing medical products harnessing the potent anti-inflammatory and anti-oxidant properties of blackberries. Based on research by Russ Mumper, pharmacy.
• NanoMed Pharmaceuticals is developing improved therapeutic and diagnostic products to treat or detect cancer and other serious diseases. The company is also developing a blackraspberry gel for oral chemoprevention. Based on research by Russ Mumper and Michael Jay, pharmacy. Corporate offices in Kalamazoo, MI.
• Outrider Technologies is developing substituted pentacene compounds for use in semiconductors and other electronic applications. Based on research by John Anthony, chemistry.
• ParaTechs (2 licenses) is developing enhancements of the baculovirus expression system for use in protecting crops from insect pests and TSP 14 and polydnavirus cys-motif proteins for use in protecting crops for insect pests. Based on research by Bruce Webb, entomology. Corporate office in Lexington, KY.
• SenseOmics is developing a diagnostic test for determination of prostacyclin in plasma. Based on licenses by Sylvia Daunert, chemistry. Corporate office in Lexington, KY.
• Tribo Flow Separations is developing a monitoring system for detecting bacterial contamination in liquids. Based on research by Fred Payne, ag. engineering; Clair Hicks, animal sciences; John Stencel, Center for Applied Energy Research. Corporate office in Lexington, KY.

FY 2005 Licenses to UK startups

FY 2012  | FY 2011  | FY 2010  | FY 2009  | FY 2008  | FY 2007  | FY 2006  | FY 2005

• Insys Therapeutics develops morphine-6-sulfate analogues for use in the treatment of pain. Based on research by Peter Crooks, pharmacy. Corporate office in Chicago, IL.
• Outrider Technologies develops substituted pentacene compounds for use in semiconductors and other electronic applications. Based on research by John Anthony, chemistry.
• Prescient Medical develops diagnostic equipment for identifying vulnerable plaque in the circulatory system. Based on research by Robert Lodder, pharmacy. Corporate office in Doylestown, PA.